CRGGF(CRGGF)
CRGGF
No analyst ratings available
No analyst price targets available for CRGGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $101.02B | $102.57B | $104.15B | $112.40B | $120.26B |
| Low | $96.72B | $96.25B | $98.72B | $106.54B | $113.99B |
| High | $111.49B | $106.96B | $111.76B | $120.61B | $129.04B |
| EBITDA Avg | $13.48B | $13.69B | $13.90B | $15.00B | $16.05B |
| Low | $12.91B | $12.85B | $13.18B | $14.22B | $15.21B |
| High | $14.88B | $14.28B | $14.92B | $16.10B | $17.22B |
| EBIT Avg | $9.73B | $9.88B | $10.03B | $10.83B | $11.58B |
| Low | $9.32B | $9.27B | $9.51B | $10.26B | $10.98B |
| High | $10.74B | $10.30B | $10.76B | $11.62B | $12.43B |
| Net Income Avg | $3.56B | $3.74B | $4.02B | $4.36B | $4.93B |
| Low | $3.32B | $3.49B | $3.75B | $4.07B | $4.60B |
| High | $3.90B | $4.10B | $4.40B | $4.78B | $5.40B |
| EPS Avg | $1.56 | $1.63 | $1.76 | $1.91 | $2.15 |
| Low | $1.45 | $1.52 | $1.64 | $1.78 | $2.01 |
| High | $1.70 | $1.79 | $1.92 | $2.09 | $2.36 |
| Analysts (Rev / EPS) | 16 / 1 | 15 / 1 | 6 / 1 | 11 / 1 | 7 / 1 |